Economic Evaluation of Targeted Therapies for Anaplastic Lymphoma Kinase– and ROS1 Fusion–Positive Non–Small Cell Lung Cancer in India We selected 250 consecutive participants from the SECOC ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

while Rozlytrek got a green light in Japan in July and in the US last month for NTRK fusion cancers in patients over 12, as well as an FDA nod for a second indication – ROS1-positive metastatic ...

The study “continues to confirm that RET fusions are clinically targetable alterations, placing them in the company of activating EGFR/ALK/ROS1 alterations,” said Drilon. “We are encouraged ...

临床实践指南的更新极大地推动了诊疗规范化的进程。在不到一年内，以「快速、准确」特点著称的《美国国家综合癌症网络（NCCN）非小细胞肺癌（NSCLC）指南》已更新了十一个版本。本文中笔者与您一同梳理 2024 年该指南的更新亮点内容。一、2024 ...